News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
78,207 Results
Type
Article (5215)
Company Profile (28)
Press Release (72963)
Section
Business (26030)
Career Advice (63)
Deals (4054)
Drug Delivery (8)
Drug Development (6690)
Employer Resources (5)
FDA (1389)
Job Trends (1800)
News (35108)
Policy (2808)
Tag
2025 Best Places to Work (2)
2026 Best Places to Work (1)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Genetown Standard (1)
Academia (454)
Accelerated approval (6)
ADA (3)
Allergies (5)
Alliances (7717)
ALS (22)
Alzheimer's disease (116)
Antibody-drug conjugate (ADC) (65)
Approvals (1466)
Artificial intelligence (170)
ASCO (53)
Autoimmune disease (26)
Automation (18)
Bankruptcy (28)
Belgium (1)
Best Places to Work (1388)
BIO (6)
Biologics (3)
BIOSECURE Act (12)
Biosimilars (6)
BioSpace Insights (6)
Biotechnology (22)
Bispecific (3)
Bladder cancer (22)
Brain cancer (13)
Breast cancer (161)
Cancer (1039)
Cardiovascular disease (58)
Career advice (64)
Career pathing (2)
CAR-T (51)
CDC (1)
CDMO (16)
Celiac Disease (2)
Cell therapy (155)
Cervical cancer (3)
Clinical research (5706)
Collaboration (418)
Commercialization (1)
Compensation (55)
Complete response letters (2)
COVID-19 (226)
CRISPR (60)
CRO (1)
C-suite (187)
Cystic fibrosis (11)
Data (1097)
Depression (15)
Dermatology (5)
Diabetes (58)
Diagnostics (1741)
Digital health (5)
Diversity, equity & inclusion (2)
Drug discovery (48)
Drug pricing (1)
Drug shortages (1)
Duchenne muscular dystrophy (19)
Earnings (7464)
Editorial (1)
Employer branding (1)
Employer resources (5)
ESMO (51)
Events (10432)
Executive appointments (172)
FDA (1718)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (188)
Gene editing (137)
Generative AI (8)
Gene therapy (132)
GLP-1 (53)
Government (344)
Guidances (46)
Healthcare (1653)
Hematology (24)
HIV (32)
Huntington's disease (12)
IgA nephropathy (3)
Immunology and inflammation (12)
Immuno-oncology (13)
Indications (24)
Infectious disease (263)
Inflammatory bowel disease (14)
Influenza (10)
Intellectual property (27)
Interviews (5)
IPO (1497)
Job creations (454)
Job search strategy (60)
JPM (2)
Kidney disease (10)
Labor market (4)
Layoffs (24)
Legal (729)
Licensing (4)
Liver cancer (12)
Longevity (10)
Lung cancer (171)
Lung diease (2)
Lymphoma (45)
Machine learning (13)
Management (2)
Manufacturing (107)
MASH (8)
Medical device (730)
Medtech (749)
Mergers & acquisitions (2691)
Metabolic disorders (92)
mRNA (42)
Multiple sclerosis (6)
NASH (1)
Netherlands (2)
Neurodegenerative disease (43)
Neuropsychiatric disorders (6)
Neuroscience (269)
NextGen: Class of 2026 (459)
Non-profit (323)
Now hiring (7)
Obesity (20)
Opinion (34)
Ovarian cancer (16)
Pain (18)
Pancreatic cancer (52)
Parkinson's disease (43)
Partnered (3)
Patents (57)
Patient recruitment (56)
Patient selection (6)
Peanut (2)
People (7824)
Peptides (2)
Pharmaceutical (2)
Phase 1 (1925)
Phase 2 (2404)
Phase 3 (2031)
Pipeline (1213)
Policy (19)
Postmarket research (283)
Preclinical (907)
Press Release (23)
Prostate cancer (41)
Radioligand (1)
Radiopharmaceuticals (19)
Rare diseases (161)
Real estate (527)
Regenerative medicine (3)
Regulatory (2172)
Reports (10)
Research institute (564)
Resumes & cover letters (2)
Rett syndrome (9)
RNA editing (2)
RSV (8)
Schizophrenia (13)
Series A (34)
Series B (18)
Sickle cell disease (32)
Spinal muscular atrophy (3)
Sponsored (5)
Startups (481)
Stem cells (2)
Stomach cancer (1)
Supply chain (9)
Tariffs (1)
Vaccines (62)
Venture capital (6)
Weight loss (8)
Women's health (3)
Date
Today (15)
Last 7 days (63)
Last 30 days (323)
Last 365 days (2607)
2026 (2409)
2025 (2712)
2024 (3780)
2023 (4567)
2022 (7678)
2021 (7599)
2020 (6434)
2019 (4473)
2018 (3340)
2017 (4116)
2016 (3972)
2015 (4688)
2014 (3119)
2013 (2420)
2012 (2379)
2011 (2319)
2010 (2148)
Location
Africa (76)
Alabama (11)
Alaska (1)
Arizona (27)
Arkansas (1)
Asia (3257)
Australia (484)
California (1680)
Canada (223)
China (113)
Colorado (46)
Connecticut (74)
Delaware (23)
Europe (22997)
Florida (195)
Georgia (9)
Hawaii (2)
Idaho (1)
Illinois (81)
India (24)
Indiana (30)
Iowa (13)
Japan (57)
Kansas (8)
Kentucky (5)
Louisiana (3)
Maine (6)
Maryland (229)
Massachusetts (1155)
Michigan (16)
Minnesota (28)
Mississippi (1)
Missouri (20)
Montana (2)
Nebraska (6)
Nevada (12)
New Hampshire (4)
New Jersey (287)
New Mexico (12)
New York (308)
North Carolina (295)
North Dakota (10)
Northern California (825)
Ohio (35)
Oregon (4)
Pennsylvania (249)
Rhode Island (12)
South America (88)
South Carolina (4)
Southern California (709)
Tennessee (15)
Texas (321)
United States (5231)
Utah (64)
Virginia (55)
Washington D.C. (4)
Washington State (79)
Wisconsin (26)
78,207 Results for "genomics plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
In matched multi-center cohorts, Telo Genomics is expanding comparative evaluation of blood-based TELO-MRD against Adaptive Biotechnologies’ clonoSEQ next-generation sequencing MRD testing.
October 29, 2026
·
6 min read
Press Releases
Telo Genomics Announces Term Sheet Providing an Option for Exclusive Worldwide License to AI Technology for Automated Detection of Rare Malignant Cells
Agreement with the University of Manitoba and Technion Research and Development Foundation Ltd. provides an option for a license that could expand Telo Genomics’ liquid-biopsy platform for cancer screening, diagnosis, treatment selection and disease monitoring.
November 18, 2026
·
6 min read
Press Releases
Glioblastoma Foundation’s Genomic Testing & Research Laboratory Now Accepting Patient Samples for Genomic Testing
November 1, 2026
·
4 min read
Press Releases
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment
Clinical Study on Track to Meet Primary Endpoints with Interim Data Demonstrating Blood-Based Assay Capable of Predicting Relapse Risk Through Analysis of Genomic Instability and Telomere Architecture
July 16, 2026
·
8 min read
Press Releases
Hemogenyx Pharmaceuticals PLC - Chairman Receives Prestigious Award
November 19, 2026
·
3 min read
Press Releases
Alkermes plc Reports Third Quarter 2026 Financial Results
November 3, 2026
·
1 min read
Press Releases
Telo Genomics Announces $250,000 Term Loan Facility
Non-dilutive secured term loan from BrightArc Capital to fund operating expenses.
November 6, 2026
·
4 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Feasibility Study Agreement
October 19, 2026
·
6 min read
Press Releases
10x Genomics Reports Third Quarter 2026 Financial Results
November 6, 2026
·
10 min read
Press Releases
Ultima Genomics Launches Paired-End Sequencing and Solaris 2.0 Max at ASHG 2026, Doubling Output and Enabling the $60 Genome
October 20, 2026
·
6 min read
1 of 7,821
Next